SCHEMBL505555

SCHEMBL505555

COC(=O)c1cccc(NC(=O)c2ccc(-c3ccccc3)cc2)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
DHODH Q02127 1/20 0.61
TSHR P16473 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
PDCD1 Q15116 1/20 0.58
CD274 Q9NZQ7 1/20 0.58
KDM4E B2RXH2 5/20 0.55
MEN1 O00255 3/20 0.55
MAPT P10636 3/20 0.55
KMT2A Q03164 3/20 0.55
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
PTPN1 P18031 1/20 0.55
APOBEC3A P31941 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
HPGD P15428 4/20 0.53
MAPK10 P53779 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9129050 0.92 TSHR (0.61) NPC1RAB9ATSHRCYP1A2CYP2D6
SCHEMBL207099 0.88 TSHR (0.52) NPC1RAB9ADHODHTSHRCYP1A2
SCHEMBL204780 0.87 MKNK1 (0.54) NPC1RAB9ATSHRCYP1A2CYP2D6
SCHEMBL14075405 0.86 TSHR (0.70) NPC1RAB9ADHODHTSHRCYP1A2
SCHEMBL6154631 0.86 DHODH (0.77) NPC1RAB9ADHODHPDCD1CD274
SCHEMBL505634 0.85 PDCD1 (0.60) NPC1RAB9ADHODHTSHRCYP1A2
SCHEMBL206176 0.84 TRPV1 (0.52) NPC1RAB9ATSHRCYP1A2CYP2D6
SCHEMBL3920156 0.83 TSHR (0.58) NPC1RAB9ATSHRCYP1A2CYP2D6
SCHEMBL204144 0.82 HSD17B10 (0.54) NPC1RAB9ATSHRCYP1A2CYP2D6
SCHEMBL204594 0.80 TTK (0.51) KDM4EMEN1MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
EP-2414328-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Merck Serono S.A. (CH) 2012-02-08 EP disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD NPC1 3171/4885RAB9A 1436/4885DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.